$130.51
▲ +$0.29
(+0.22%)
Vol 75K
Mkt Cap
$5.7B
ROE
-23.7%
Margin
-30.6%
Beta
0.86
Div Yield
1.04%
52W
$100–$139
Wall Street Consensus
17 analysts · Apr 20261
Strong Buy
4
Buy
11
Hold
1
Sell
0
Strong Sell
29.4%
Buy Rating
Price Chart
Similar Stocks
PEN
Penumbra Inc
P/E 73.4
$13.0B
GMED
Globus Medical Inc
P/E 23.7
$12.8B
BAX
Baxter International Inc
$9.3B
MASI
Masimo Corp
$7.0B
GKOS
Glaukos Corp
$7.1B
NVST
Envista Holdings Corp
P/E 93.9
$4.4B
IRTC
iRhythm Holdings, Inc
$5.7B
TMDX
Transmedics Group Inc
P/E 45.3
$4.2B
ITGR
Integer Holdings Corp
P/E 29.6
$3.0B
ABT
Abbott Laboratories
P/E 26.3
$165.2B
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $3.77 | $1.93 | $-1.84 |
| Sep 2025 | $3.42 | $3.67 | +$0.25 |
| Jun 2025 | $3.40 | $3.73 | +$0.33 |
| Mar 2025 | $2.95 | $2.91 | $-0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $795.4M | $700.7M | $780.9M | $913.0M | -$401.9M |
| Net Income | — | -$136.7M | $95.0M | $122.6M | -$408.9M | -$714.3M |
Fundamentals Trend
| Metric | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | -23.7% | -23.7% |
| P/E (TTM) | — | — |
| Net Margin | -30.6% | -30.6% |
| Gross Margin | 53.3% | 53.3% |
| D/E Ratio | — | — |
| Current Ratio | 2.54 | 2.54 |
Key Ratios
ROA (TTM)
-12.3%
P/S (TTM)
1.93
P/B
1.7
EPS (TTM)
$-20.56
CF/Share
$13.58
Rev Growth 3Y
-10.6%
52W High
$138.93
52W Low
$100.18
$100.18
52-Week Range
$138.93
Financial Health
Free Cash Flow
$151.6M
Net Debt
$2.3B
Cash
$378.6M
Total Debt
$2.7B
As of Dec 31, 2025
How does TFX compare to Health Care peers?
Peer group: Peers · Health Care (Peers) · 10 companies
TFX valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(34.5)
vs Peers
vs Industry
Fair value
P/S ratio
1.8
▼
56%
below
peers
(4.0)
vs Peers
vs Industry
Pricier
P/B ratio
1.7
▼
67%
below
peers
(5.2)
vs Peers
vs Industry
Pricier
Div yield
1.1%
▲
7%
above
peers
(1.1%)
vs Peers
vs Industry
Low yield
TFX profitability vs Health Care peers
ROE
-23.7%
▼
287%
below
peers
(-6.1%)
vs Peers
vs Industry
Weak
Net margin
-30.6%
▼
995%
below
peers
(-2.8%)
vs Peers
vs Industry
Weak
Gross margin
53.3%
▼
5%
below
peers
(55.9%)
vs Peers
vs Industry
Weak
ROA
-12.3%
▼
556%
below
peers
(-1.9%)
vs Peers
vs Industry
Weak
TFX financial health vs Health Care peers
D/E ratio
—
▼
0%
below
peers
(106.5)
vs Peers
vs Industry
In line
Current ratio
2.5
▼
17%
below
peers
(3.1)
vs Peers
vs Industry
Low liquidity
Beta
0.8
▲
2%
above
peers
(0.8)
vs Peers
vs Industry
Less volatile
TFX fundamentals radar
TFX
Peer median
Industry
TFX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TFX vs peers: key metrics
Insider Activity
NeutralBuys
8
Sells
0
DEREN JOHN
Chief Financial Officer · Mar 03
award
13784 shs
WINTERS JAMES
Officer · Mar 03
award
13007 shs
LOGUE DANIEL V.
General Counsel · Mar 03
award
9853 shs
HICKS CAMERON P
Officer · Mar 03
award
8096 shs
DEREN JOHN
Chief Financial Officer · Feb 23
award
161 shs
WINTERS JAMES
Officer · Feb 23
award
354 shs
LOGUE DANIEL V.
General Counsel · Feb 23
award
443 shs
HICKS CAMERON P
Officer · Feb 23
award
352 shs
Last 90 days
Insider Buy Returns
HAGGERTY GRETCHEN R
Aug 06, 2025
$57375
+13.75%
RYU JAEWON
Aug 05, 2025
$172500
+13.49%
KELLY LIAM J
Aug 05, 2025
$172605
+13.42%
RANDLE STUART A
Aug 05, 2025
$115860
+12.64%
KRAKAUER ANDREW A
Aug 05, 2025
$115250
+13.24%
Top Holders
Top 5: 47.97%Blackrock Inc.
12.08%
$632.1M
Vanguard Group Inc
10.77%
$563.4M
T. Rowe Price Investment Ma…
9.86%
$515.8M
Janus Henderson Group PLC
9.61%
$502.7M
Morgan Stanley
5.65%
$295.9M
As of Dec 31, 2025
Dividends
$1.36
/ year
Mar 06, 2026
$0.3400
Nov 14, 2025
$0.3400
Aug 15, 2025
$0.3400
May 20, 2025
$0.3400
Mar 07, 2025
$0.3400
Nov 15, 2024
$0.3400
Aug 15, 2024
$0.3400
May 14, 2024
$0.3400